Oncology Journals
Oncology journals cover clinical cancer care, translational oncology, tumour biology, prevention, diagnostics and treatment research. Citation patterns can vary between highly clinical and laboratory-focused titles.
257
Approved journals
Approved journals
257
With JIF
With JIF
97
Q1 journals
Q1 journals
232.400
Highest available JIF
Highest available JIF
Filter Oncology Journals
Oncology Journal List
257 results| Journal | JIF | 5-Year JIF | JCI | Quartile | Publisher |
|---|---|---|---|---|---|
| CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 1055-9965 |
3.400 | 4.200 | 0.900 | Q1 | AMER ASSOC CANCER RESEARCH |
| Current Oncology 1198-0052 |
3.400 | 3.300 | 0.640 | Q2 | MDPI |
| Cancer Research Communications N/A |
3.300 | 3.300 | 0.750 | Q2 | AMER ASSOC CANCER RESEARCH |
| Clinical Lung Cancer 1525-7304 |
3.300 | 3.300 | 0.780 | Q2 | CIG MEDIA GROUP, LP |
| Frontiers in Oncology 2234-943X |
3.300 | 3.800 | 0.680 | Q2 | FRONTIERS MEDIA SA |
| Lung Cancer-Targets and Therapy N/A |
3.300 | 3.200 | 0.680 | Q2 | DOVE MEDICAL PRESS LTD |
| Physics & Imaging in Radiation Oncology N/A |
3.300 | 3.400 | 0.970 | Q1 | ELSEVIER |
| CANCER CYTOPATHOLOGY 1934-662X |
3.200 | 3.600 | 0.910 | Q2 | WILEY |
| Cardio-Oncology N/A |
3.200 | 3.300 | 0.780 | Q2 | BMC |
| Clinical Colorectal Cancer 1533-0028 |
3.200 | 3.000 | 0.690 | Q2 | CIG MEDIA GROUP, LP |
| Journal of Cancer 1837-9664 |
3.200 | 3.200 | 0.720 | Q2 | IVYSPRING INT PUBL |
| Journal of Immunotherapy and Precision Oncology 2666-2345 |
3.200 | 0.000 | 0.530 | Q2 | Innovative Healthcare Institute |
| NAR Cancer 2632-8674 |
3.200 | 3.900 | 0.710 | Q2 | OXFORD UNIV PRESS |
| Oncology and Therapy 2366-1070 |
3.200 | 3.400 | 0.560 | Q2 | SPRINGER |
| Radiation Oncology N/A |
3.200 | 3.800 | 0.890 | Q1 | BMC |
| SEMINARS IN RADIATION ONCOLOGY 1053-4296 |
3.200 | 4.600 | 0.830 | Q1 | W B SAUNDERS CO-ELSEVIER INC |
| World Journal of Clinical Oncology 2218-4333 |
3.200 | 3.200 | 0.450 | Q2 | BAISHIDENG PUBLISHING GROUP INC |
| Cancer Medicine 2045-7634 |
3.100 | 3.500 | 0.690 | Q2 | WILEY |
| JOURNAL OF NEURO-ONCOLOGY 0167-594X |
3.100 | 3.600 | 0.810 | Q2 | SPRINGER |
| Advances in Cancer Biology-Metastasis N/A |
3.000 | 2.700 | 0.570 | Q2 | ELSEVIER |
| Anti-Cancer Agents in Medicinal Chemistry 1871-5206 |
3.000 | 2.800 | 0.590 | Q2 | BENTHAM SCIENCE PUBL LTD |
| Brain Tumor Pathology 1433-7398 |
3.000 | 2.800 | 0.650 | Q2 | SPRINGER JAPAN KK |
| BREAST CANCER RESEARCH AND TREATMENT 0167-6806 |
3.000 | 3.600 | 0.660 | Q2 | SPRINGER |
| CLINICAL ONCOLOGY 0936-6555 |
3.000 | 3.300 | 0.670 | Q2 | ELSEVIER SCIENCE LONDON |
| International Journal of Breast Cancer 2090-3170 |
3.000 | 2.900 | 0.500 | Q2 | WILEY |
| JCO Global Oncology N/A |
3.000 | 3.700 | 0.640 | Q2 | LIPPINCOTT WILLIAMS & WILKINS |
| SUPPORTIVE CARE IN CANCER 0941-4355 |
3.000 | 3.400 | 0.990 | Q1 | SPRINGER |
| American Journal of Cancer Research 2156-6976 |
2.900 | 4.200 | 0.690 | Q2 | E-CENTURY PUBLISHING CORP |
| Breast Cancer 1340-6868 |
2.900 | 3.400 | 0.860 | Q1 | SPRINGER JAPAN KK |
| Discover Oncology N/A |
2.900 | 3.000 | 0.650 | Q2 | SPRINGER |
| Journal of Cancer Survivorship 1932-2259 |
2.900 | 3.800 | 0.790 | Q1 | SPRINGER |
| JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY 0731-8898 |
2.900 | 2.400 | 0.800 | Q2 | BEGELL HOUSE INC |
| Asia-Pacific Journal of Oncology Nursing 2347-5625 |
2.800 | 2.800 | 1.100 | Q1 | ELSEVIER SCIENCE INC |
| Cancer Pathogenesis and Therapy 2097-2563 |
2.800 | 2.800 | 0.520 | Q2 | ELSEVIER |
| GENES CHROMOSOMES & CANCER 1045-2257 |
2.800 | 3.300 | 0.720 | Q2 | WILEY |
| Infectious Agents and Cancer 1750-9378 |
2.800 | 3.100 | 0.610 | Q2 | BMC |
| INTEGRATIVE CANCER THERAPIES 1534-7354 |
2.800 | 3.400 | 0.630 | Q2 | SAGE PUBLICATIONS INC |
| International Journal of Clinical Oncology 1341-9625 |
2.800 | 3.000 | 0.580 | Q2 | SPRINGER JAPAN KK |
| JCO Clinical Cancer Informatics 2473-4276 |
2.800 | 3.900 | 0.630 | Q2 | LIPPINCOTT WILLIAMS & WILKINS |
| JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 0171-5216 |
2.800 | 3.100 | 0.610 | Q2 | SPRINGER |
| Technical Innovations & Patient Support in Radiation Oncology N/A |
2.800 | 0.000 | 0.680 | Q2 | ELSEVIER |
| TECHNOLOGY IN CANCER RESEARCH & TREATMENT 1533-0346 |
2.800 | 2.500 | 0.550 | Q2 | SAGE PUBLICATIONS INC |
| Advances in Radiation Oncology N/A |
2.700 | 2.500 | 0.650 | Q2 | ELSEVIER INC |
| Clinical and Translational Radiation Oncology N/A |
2.700 | 3.100 | 0.720 | Q2 | ELSEVIER IRELAND LTD |
| Clinical Genitourinary Cancer 1558-7673 |
2.700 | 2.500 | 0.880 | Q2 | CIG MEDIA GROUP, LP |
| European Journal of Oncology Nursing 1462-3889 |
2.700 | 3.400 | 0.990 | Q1 | ELSEVIER SCI LTD |
| HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA 0889-8588 |
2.700 | 3.200 | 0.660 | Q2 | W B SAUNDERS CO-ELSEVIER INC |
| JMIR Cancer 2369-1999 |
2.700 | 3.300 | 0.630 | Q3 | JMIR PUBLICATIONS, INC |
| Journal of Geriatric Oncology 1879-4068 |
2.700 | 2.800 | 0.650 | Q3 | ELSEVIER |
| Cancer Control 1073-2748 |
2.600 | 2.700 | 0.550 | Q3 | SAGE PUBLICATIONS INC |
| Cancer Genomics & Proteomics 1109-6535 |
2.600 | 2.400 | 0.680 | Q2 | INT INST ANTICANCER RESEARCH |
| Cancer Management and Research 1179-1322 |
2.600 | 2.600 | 0.520 | Q3 | DOVE MEDICAL PRESS LTD |
| Cancer Prevention Research 1940-6207 |
2.600 | 3.000 | 0.640 | Q3 | AMER ASSOC CANCER RESEARCH |
| Future Oncology 1479-6694 |
2.600 | 2.800 | 0.570 | Q3 | TAYLOR & FRANCIS LTD |
| Cancer Informatics N/A |
2.500 | 2.400 | 0.610 | Q2 | SAGE PUBLICATIONS LTD |
| CANCER NURSING 0162-220X |
2.500 | 2.800 | 0.940 | Q1 | LIPPINCOTT WILLIAMS & WILKINS |
| Chinese Clinical Oncology 2304-3865 |
2.500 | 2.900 | 0.320 | Q3 | AME PUBLISHING COMPANY |
| Clinical & Translational Oncology 1699-048X |
2.500 | 2.700 | 0.570 | Q3 | SPRINGER INT PUBL AG |
| Clinical Breast Cancer 1526-8209 |
2.500 | 2.700 | 0.630 | Q3 | CIG MEDIA GROUP, LP |
| EUROPEAN JOURNAL OF CANCER PREVENTION 0959-8278 |
2.500 | 2.100 | 0.540 | Q3 | LIPPINCOTT WILLIAMS & WILKINS |
| Neuro-Oncology Practice 2054-2577 |
2.500 | 2.800 | 0.680 | Q2 | OXFORD UNIV PRESS |
| Oncologie 1292-3818 |
2.500 | 1.900 | 0.390 | Q3 | WALTER DE GRUYTER GMBH |
| SEMINARS IN ONCOLOGY 0093-7754 |
2.500 | 4.100 | 0.380 | Q3 | W B SAUNDERS CO-ELSEVIER INC |
| World Journal of Gastrointestinal Oncology 1948-5204 |
2.500 | 2.700 | 0.460 | Q2 | BAISHIDENG PUBLISHING GROUP INC |
| World Journal of Surgical Oncology N/A |
2.500 | 2.800 | 0.930 | Q1 | BMC |
| Cancer Treatment and Research Communications 2468-2942 |
2.400 | 0.000 | 0.520 | Q3 | ELSEVIER |
| CURRENT OPINION IN ONCOLOGY 1040-8746 |
2.400 | 2.800 | 0.380 | Q3 | LIPPINCOTT WILLIAMS & WILKINS |
| Hereditary Cancer in Clinical Practice 1731-2302 |
2.400 | 2.000 | 0.360 | Q3 | BMC |
| Journal of Breast Cancer 1738-6756 |
2.400 | 2.200 | 0.510 | Q3 | KOREAN BREAST CANCER SOC |
| NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL 0163-5581 |
2.400 | 2.700 | 0.460 | Q3 | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD |
| Surgical Oncology Clinics of North America 1055-3207 |
2.400 | 2.200 | 0.770 | Q1 | W B SAUNDERS CO-ELSEVIER INC |
| SURGICAL ONCOLOGY-OXFORD 0960-7404 |
2.400 | 2.300 | 0.730 | Q1 | ELSEVIER SCI LTD |
| CANCER CHEMOTHERAPY AND PHARMACOLOGY 0344-5704 |
2.300 | 2.500 | 0.640 | Q3 | SPRINGER |
| Cancer Epidemiology 1877-7821 |
2.300 | 2.800 | 0.670 | Q2 | ELSEVIER SCI LTD |
| CURRENT PROBLEMS IN CANCER 0147-0272 |
2.300 | 2.200 | 0.530 | Q3 | MOSBY-ELSEVIER |
| PATHOLOGY & ONCOLOGY RESEARCH 1219-4956 |
2.300 | 2.300 | 0.680 | Q2 | FRONTIERS MEDIA SA |
| PEDIATRIC BLOOD & CANCER 1545-5009 |
2.300 | 2.800 | 0.690 | Q2 | WILEY |
| Thoracic Cancer 1759-7706 |
2.300 | 2.700 | 0.580 | Q2 | WILEY |
| UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 1078-1439 |
2.300 | 2.300 | 0.720 | Q2 | ELSEVIER SCIENCE INC |
| ACTA ONCOLOGICA 0284-186X |
2.200 | 3.000 | 0.510 | Q3 | Medical Journal Sweden AB |
| ANTI-CANCER DRUGS 0959-4973 |
2.200 | 1.900 | 0.610 | Q3 | LIPPINCOTT WILLIAMS & WILKINS |
| CANCER JOURNAL 1528-9117 |
2.200 | 2.400 | 0.330 | Q3 | LIPPINCOTT WILLIAMS & WILKINS |
| JAPANESE JOURNAL OF CLINICAL ONCOLOGY 0368-2811 |
2.200 | 2.400 | 0.400 | Q3 | OXFORD UNIV PRESS |
| MedComm-Oncology 2769-6448 |
2.200 | 2.200 | 0.320 | Q3 | WILEY |
| NEOPLASMA 0028-2685 |
2.200 | 2.200 | 0.510 | Q3 | AEPRESS SRO |
| Oncology Letters 1792-1074 |
2.200 | 2.400 | 0.520 | Q3 | SPANDIDOS PUBL LTD |
| Radiation Oncology Journal 2234-3156 |
2.200 | 2.300 | 0.430 | Q3 | KOREAN SOC THERAPEUTIC RADIOLOGY & ONCOLOGY |
| Radiology and Oncology 1318-2099 |
2.200 | 2.900 | 0.530 | Q2 | SCIENDO |
| World Journal of Oncology 1920-4531 |
2.200 | 6.800 | 0.460 | Q3 | ELMER PRESS INC |
| CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 1084-9785 |
2.100 | 2.400 | 0.560 | Q2 | MARY ANN LIEBERT, INC |
| CANCER CAUSES & CONTROL 0957-5243 |
2.100 | 2.400 | 0.590 | Q2 | SPRINGER |
| Cancer Genetics 2210-7762 |
2.100 | 1.800 | 0.440 | Q3 | ELSEVIER SCIENCE INC |
| Precision Radiation Oncology 2398-7324 |
2.100 | 0.000 | 0.550 | Q2 | WILEY |
| Cancer Innovation 2770-9191 |
2.000 | 2.000 | 0.380 | Q3 | WILEY |
| Familial Cancer 1389-9600 |
2.000 | 2.300 | 0.480 | Q3 | SPRINGER |
| Journal of Cancer Policy N/A |
2.000 | 1.700 | 0.710 | Q3 | ELSEVIER SCI LTD |
| Journal of Gastrointestinal Oncology 2078-6891 |
2.000 | 2.300 | 0.450 | Q3 | AME PUBLISHING COMPANY |
| Journal of Skin Cancer 2090-2905 |
2.000 | 1.600 | 0.450 | Q3 | WILEY |
| Prostate Cancer 2090-3111 |
2.000 | 1.800 | 0.230 | Q3 | WILEY |
| Reports of Practical Oncology and Radiotherapy 1507-1367 |
2.000 | 1.600 | 0.350 | Q3 | VIA MEDICA |
Comparing oncology journals
Consider tumour type, clinical or translational focus, readership, indexing and article type together with journal-level metrics.